How much weight should I lose on Mounjaro — and what affects the answer?

Step 1: understand what the trial averages mean for you personally

The SURMOUNT-1 trial, published in the New England Journal of Medicine, enrolled around 2,500 adults with obesity and followed them for 72 weeks. At tirzepatide 15mg, average body-weight reduction was roughly 20–21%. Those are population averages from a controlled trial setting, they tell you what the medicine is capable of at scale, not what your body will do in the next six months.

A few things reliably shape individual results. The dose you eventually reach matters a great deal: someone who tolerates 15mg will typically lose more than someone who stays at 5mg because their system cannot go higher. Time on treatment matters too, the first months are often slower as the dose steps up cautiously. And lifestyle input, particularly protein intake and keeping active, affects how much of the weight lost comes from fat rather than lean mass. How much weight you should expect to lose on tirzepatide is a question worth sitting with before you start, so your expectations are grounded from the beginning.

The short version: a realistic private target for most people on a therapeutic dose, over 12 months, is somewhere between 10% and 20% of starting body weight. If you want a more detailed breakdown of how much weight you should be losing on Mounjaro, that page walks through what progress typically looks like at each stage of treatment. Below 5% loss after six months at the highest tolerated dose is the threshold NICE uses to reassess whether to continue. That is the clinical floor, not the ceiling.

Step 2: know what dose-related weight loss looks like week to week

Progress on Mounjaro is not a straight line. The titration schedule (starting at 2.5mg and stepping up roughly every four weeks under prescriber guidance) means the first pen or two are about settling your system rather than maximum effect. Noticeable appetite suppression tends to build as the dose climbs. Most people see their sharpest monthly losses once they are established on a therapeutic dose (7.5mg upwards for many).

Week-to-week variation is normal. Fluid shifts, hormonal cycles, and how closely you are logging intake all create noise in the number on the scales. What to expect each week on Mounjaro is covered in detail separately, but the practical point is this: judge progress monthly, not daily. Prescribers at nume look at trajectory at every clinical review, not a single weigh-in.

If you are curious about what to expect at a specific step in the titration schedule, results at 5mg specifically are worth reading before your dose increase conversation.

Step 3: price context, what you are actually paying for when you start treatment

Mounjaro is available privately in the UK, and private prices have shifted significantly since Eli Lilly raised the list price in September 2025. The highest-dose pen's list price moved from around £122 to around £330; typical private prices across doses and providers now range roughly £149–£375 per month, as widely reported at the time. Those figures vary by dose and provider, and a lower headline price does not always mean a lower total cost.

Many quoted prices exclude the clinical consultation, the prescription fee, delivery, and any aftercare if questions arise between doses. When those are added, the gap between the cheapest listing and a genuinely all-in service narrows considerably. More on the full cost of Mounjaro in the UK (including what different dose levels typically cost) is set out on the pricing page.

At nume, one price covers the consultation, the prescription, the medicine itself, free next-working-day delivery (your pen arrives in a plain, unbranded DPD box with live tracking), and seven-day aftercare. We are not the cheapest option available. That is a deliberate choice: clinician time, identity verification, live weight checks on video, and a proper supply-chain relationship with authorised distributors all cost money. For a prescription medicine that works by changing how your body responds to food, the service around the prescription matters as much as the price on the label.

Step 4: how to set a realistic personal target before your consultation

A useful starting point is the NHS BMI calculator, which gives you a concrete number to discuss. From there, consider what a 10–15% reduction in your current weight would mean practically (how you would feel, what health markers might improve) rather than anchoring to a trial headline.

Eligibility for private treatment with Mounjaro requires a BMI of 30 or above, or 27 or above alongside a weight-related condition such as high blood pressure, type 2 diabetes or obstructive sleep apnoea. Ethnic-background thresholds can be 2.5 kg/m² lower under UK guidance. The prescriber also looks at your medical history, current medicines and other factors, BMI alone does not determine the outcome. Details on what dose is appropriate and on long-term maintenance costs are worth reading alongside this page.

For a broader look at what the treatment programme involves, our Mounjaro overview covers the full picture from mechanism to aftercare. And if you are still weighing up which treatment suits your situation, our weight-loss treatments page sets out the options side by side.